BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12423667)

  • 1. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.
    Thakker DR; Standifer KM
    Neuropharmacology; 2002 Nov; 43(6):979-90. PubMed ID: 12423667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
    Mandyam CD; Thakker DR; Christensen JL; Standifer KM
    J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity.
    Mandyam CD; Thakker DR; Standifer KM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):965-72. PubMed ID: 12750434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.
    Thakker DR; Standifer KM
    Brain Res Mol Brain Res; 2002 Sep; 105(1-2):38-46. PubMed ID: 12399106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells.
    Mandyam CD; Altememi GF; Standifer KM
    Eur J Pharmacol; 2000 Aug; 402(1-2):R1-37. PubMed ID: 10940375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
    Hawes BE; Fried S; Yao X; Weig B; Graziano MP
    J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
    Li AH; Wang HL
    J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.
    Ozsoy HZ; Thakker DR; Standifer KM
    Mol Pharmacol; 2005 Aug; 68(2):447-56. PubMed ID: 15890842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels.
    Murali SS; Napier IA; Rycroft BK; Christie MJ
    J Physiol; 2012 Apr; 590(7):1655-67. PubMed ID: 22371475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.
    Wang Q; Traynor JR
    Mol Pharmacol; 2013 Feb; 83(2):512-20. PubMed ID: 23197645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
    Kovoor A; Celver JP; Wu A; Chavkin C
    Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity.
    Hurlé MA
    J Neurochem; 2001 Apr; 77(2):486-92. PubMed ID: 11299311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin/orphanin FQ stimulates extracellular acidification and desensitization of the response involves protein kinase C.
    Pei G; Ling K; Pu L; Cunningham MD; Ma L
    FEBS Lett; 1997 Jul; 412(1):253-6. PubMed ID: 9257731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster of Ser/Thr residues at the C-terminus of mu-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization.
    Wang HL
    Neuropharmacology; 2000 Jan; 39(3):353-63. PubMed ID: 10698001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphanin FQ/nociceptin and mu-opioid receptor mRNA levels in human SH-SY5Y neuroblastoma cells: effects of activating the cAMP-PKA signal transduction pathway.
    Wallington CL; Peters DM; Gelb CR; Peterfreund RA
    Brain Res; 2002 Jul; 944(1-2):73-81. PubMed ID: 12106667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
    Chiou LC
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors.
    Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP
    Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo.
    Dautzenberg FM; Wichmann J; Higelin J; Py-Lang G; Kratzeisen C; Malherbe P; Kilpatrick GJ; Jenck F
    J Pharmacol Exp Ther; 2001 Aug; 298(2):812-9. PubMed ID: 11454946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.
    Lowe JD; Sanderson HS; Cooke AE; Ostovar M; Tsisanova E; Withey SL; Chavkin C; Husbands SM; Kelly E; Henderson G; Bailey CP
    Mol Pharmacol; 2015 Aug; 88(2):347-56. PubMed ID: 26013542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
    Kramer HK; Simon EJ
    J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.